Literature DB >> 926711

[Raised plasma-prolactin levels in essential hypertension: index of reduced hypothalamic dopaminergic activity (author's transl)].

R Kolloch, K O Stumpe, M Higuchi, H Vetter, F Krück.   

Abstract

Serial measurements of plasma-prolactin concentration (HPr) and plasma-renin activity (PRA) at 30-min intervals were made in 19 male patients with essential hypertension and in 8 normotensive subjects. HPr was markedly higher in the hypertensive patients than in the normotensive controls. Patients with reduced plasma-renin activity and only slightly elevated HPr-levels showed lower urinary sodium excretion, but a more pronouced 24-h natriuretic response to i.v. furosemide than patients with normal renin and very high HPr-levels. Six patients were treated with the dopaminergic agonist bromocriptine. The drug induced a significant blood pressure reduction in five patients and normalised pressure in two patients. The data do not indicate a role for prolactin in sustaining hypertension via renal salt retaining mechanisms. It is suggested that the raised HPr-levels represent an index of altered central nervous function, characterized by reduced hypothalamic activity. The blood pressure-lowering effect of the dopaminergic agonist bromocriptine fits with the hypothesis that reduced hypothalamic dopaminergic activity might be a factor in the pathogenesis of essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 926711     DOI: 10.1007/bf01488188

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  34 in total

Review 1.  Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA).

Authors:  O Hornykiewicz
Journal:  Br Med Bull       Date:  1973-05       Impact factor: 4.291

2.  Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles.

Authors:  J H Laragh
Journal:  Am J Med       Date:  1973-09       Impact factor: 4.965

3.  Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension.

Authors:  A C Guyton; T G Coleman; A V Cowley; K W Scheel; R D Manning; R A Norman
Journal:  Am J Med       Date:  1972-05       Impact factor: 4.965

4.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

5.  Actions of prolactin on human renal function.

Authors:  D F Horrobin; I J Lloyd; A Lipton; P G Burstyn; N Durkin; K L Muiruri
Journal:  Lancet       Date:  1971-08-14       Impact factor: 79.321

6.  Report of the National Pituitary Agency. Collaborative study of the radioimmunoassay of human prolactin.

Authors:  M L Aubert; R L Becker; B B Saxena; S Raiti
Journal:  J Clin Endocrinol Metab       Date:  1974-06       Impact factor: 5.958

7.  Evidence for a physiological role of prolactin in osmoregulation in the rat after its inhibition by 2-bromo- -ergokryptine.

Authors:  B P Richardson
Journal:  Br J Pharmacol       Date:  1973-03       Impact factor: 8.739

8.  Suppression of prolactin release by a purified porcine PIF preparation and catecholamines infused into a rat hypophysial portal vessel.

Authors:  J Takahara; A Arimura; A V Schally
Journal:  Endocrinology       Date:  1974-08       Impact factor: 4.736

9.  Levodopa suppression of prolactin in nonpuerperal galactorrhea.

Authors:  W B Malarkey; L S Jacobs; W H Daughaday
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

10.  Failure of endogenous prolactin to alter renal salt and water excretion and adrenal function in man.

Authors:  G Baumann; D L Loriaux
Journal:  J Clin Endocrinol Metab       Date:  1976-09       Impact factor: 5.958

View more
  2 in total

1.  Excessive plasma dopamine increase at rest and during exercise after long-term beta-adrenoreceptor blockade in hypertensive patients.

Authors:  I W Franz; F W Lohmann; G Koch
Journal:  Br Heart J       Date:  1980-07

Review 2.  [Human prolactin (author's transl)].

Authors:  K von Werder; H K Rjosk
Journal:  Klin Wochenschr       Date:  1979-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.